Setterwalls advised Immunovia on the deal.Immunovia AB (publ), listed on Nasdaq Stockholm finalized a rights issue of units. Through the rights issue, Immunovia receives initial issue…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
